# Infliximab (Genetical Recombination) for I.V. Infusion 100 (レミケード点滴静注用１００)

> Prescription product approved in Japan and listed on the NHI drug price list (YJ code 2399402F1026). Nifuji Pharma sources it for licensed healthcare providers, institutions, and distributors; availability, documentation, and export eligibility are confirmed on inquiry.

- **YJ code:** 2399402F1026
- **Product name (Japanese):** レミケード点滴静注用１００
- **English title:** Infliximab (Genetical Recombination) for I.V. Infusion 100
- **Active ingredient:** インフリキシマブ（遺伝子組換え）
- **Active ingredient (INN):** Infliximab (Genetical Recombination)
- **Strength / unit:** １００ｍｇ１瓶
- **Route:** Injection (注射薬)
- **Therapeutic category:** 23 Digestive organ agents (消化器官用薬) › 239 Other digestive organ agents (その他の消化器官用薬)
- **Manufacturer:** Tanabe Pharma (田辺ファーマ)
- **NHI price (reference only):** JPY 35981 per １００ｍｇ１瓶
- **Regulatory status:** Approved in Japan; listed on the NHI drug price list
- **Web page:** https://www.nifujipharma.com/drugs/2399402F1026
- **JSON:** https://www.nifujipharma.com/api/drugs/2399402F1026

## How to request a quotation

Submit the contact form with the product name, quantity, and destination country: https://www.nifujipharma.com/?product=Infliximab%20(Genetical%20Recombination)%20for%20I.V.%20Infusion%20100%20(%E3%83%AC%E3%83%9F%E3%82%B1%E3%83%BC%E3%83%89%E7%82%B9%E6%BB%B4%E9%9D%99%E6%B3%A8%E7%94%A8%EF%BC%91%EF%BC%90%EF%BC%90)%20%2F%20YJ%202399402F1026#contact

Quotes are for qualified business customers only (licensed healthcare providers, medical institutions, distributors). Payment is by bank transfer in Japanese Yen. Product collection typically takes 2-4 weeks after order confirmation, followed by export procedures and shipping.